Vanda Pharmaceuticals Inc.
Treatment of schizophrenia
Last updated:
Abstract:
Aspects of the invention relate generally to the treatment of schizophrenia and to monitoring for specific adverse reactions.
Status:
Grant
Type:
Utility
Filling date:
12 Dec 2016
Issue date:
27 Jul 2021